Bridges; Alexander James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bridges; Alexander James.The latest application filed is for "selective inhibitors of clinically important mutants of the egfr tyrosine kinase".

Company Profile

3.30.23

Bridges; Alexander James - Saline MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucosylceramide synthase inhibitors for the treatment of diseases Grant 10,927,092 - Wang , et al. February 23, 2	2021-02-23
Selective Inhibitors Of Clinically Important Mutants Of The Egfr Tyrosine Kinase App 20200131176 - SONG; Yuntao ; et al.	2020-04-30
Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase Grant 10,435,388 - Song , et al. O	2019-10-08
Glucosylceramide Synthase Inhibitors For The Treatment Of Diseases App 20190263775 - Wang; Bing ; et al.	2019-08-29
Glucosylceramide synthase inhibitors for the treatment of diseases Grant 10,227,323 - Wang , et al.	2019-03-12
Selective Inhibitors Of Clinically Important Mutants Of The Egfr Tyrosine Kinase App 20190023689 - SONG; Yuntao ; et al.	2019-01-24
Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline trisodium salt Grant 9,458,188 - Kerschen , et al. October 4, 2	2016-10-04
Glucosylceramide Synthase Inhibitors For The Treatment Of Diseases App 20160229830 - Wang; Bing ; et al.	2016-08-11
Macrocyclic Compounds For The Treatment Of Proliferative Diseases App 20160214996 - Song; Yuntao ; et al.	2016-07-28
Synthesis of cyclopentaquinazolines Grant 8,809,526 - Kerschen , et al. August 19, 2	2014-08-19
Efficient Peptide Couplings And Their Use In The Synthesis And Isolation Of A Cyclopenta (g) Quinazoline Trisodium Salt App 20130345423 - Kershen; James Alan ; et al.	2013-12-26
Synthesis of Cyclopentaquinazolines App 20130211082 - Kerschen; James Alan ; et al.	2013-08-15
Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinases Grant 7,786,131 - Bridges , et al. August 31, 2	2010-08-31
Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone App 20080171728 - Bridges; Alexander James	2008-07-17
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors Grant 7,169,816 - Barrett , et al. January 30, 2	2007-01-30
Method for treating chronic pain using MEK inhibitors Grant 7,030,119 - Barrett , et al. April 18, 2	2006-04-18
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives Grant 7,019,033 - Barrett , et al. March 28, 2	2006-03-28
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20060052608 - Barrett; Stephen Douglas ; et al.	2006-03-09
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20050049429 - Barrett, Stephen Douglas ; et al.	2005-03-03
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors Grant 6,821,963 - Barrett , et al. November 23, 2	2004-11-23
Preparation of substituted quinazolines App 20040158065 - Barth, Hubert ; et al.	2004-08-12
Treatment of asthma with MEK inhibitors App 20040141924 - Bridges, Alexander James ; et al.	2004-07-22
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,713,484 - Bridges , et al. March 30, 2	2004-03-30
Treatment of asthma with MEK inhibitors Grant 6,696,440 - Bridges , et al. February 24, 2	2004-02-24
Irreversible inhibitors of tyrosine kinases App 20030229051 - Bridges, Alexander James ; et al.	2003-12-11
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family App 20030186987 - Bridges, Alexander James ; et al.	2003-10-02
Antidiabetic agents App 20030171377 - Bigge, Christopher Franklin ; et al.	2003-09-11
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives App 20030149015 - Barrett, Stephen Douglas ; et al.	2003-08-07
Irreversible inhibitors of tyrosine kinases Grant 6,602,863 - Bridges , et al. August 5, 2	2003-08-05
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,596,726 - Bridges , et al. July 22, 2	2003-07-22
Irreversible inhibitors of tyrosine kinases Grant 6,562,818 - Bridges May 13, 2	2003-05-13
Irreversible inhibitors of tyrosine kinases App 20030087881 - Bridges, Alexander James	2003-05-08
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors App 20030078428 - Barrett, Stephen Douglas ; et al.	2003-04-24
1-heterocycle substituted diarylamines Grant 6,545,030 - Barrett , et al. April 8, 2	2003-04-08
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,521,620 - Bridges , et al. Feb	2003-02-18
1-Heterocycle substituted diarylamines App 20030004193 - Barrett, Stephen Douglas ; et al.	2003-01-02
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,455,534 - Bridges , et al. Sept	2002-09-24
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives App 20020022647 - Barrett, Stephen Douglas ; et al.	2002-02-21
N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazoli n-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinases Grant 6,344,455 - Bridges , et al. Fe	2002-02-05
Irreversible inhibitors of tyrosine kinases Grant 6,344,459 - Bridges , et al. Fe	2002-02-05
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors Grant 6,310,060 - Barrett , et al. October 30, 2	2001-10-30
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family App 20010027197 - Bridges, Alexander James ; et al.	2001-10-04
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,265,410 - Bridges , et al.	2001-07-24
Method of treating or preventing septic shock by administering a MEK inhibitor Grant 6,251,943 - Barrett , et al. June 26, 2	2001-06-26
Irreversible bicyclic inhibitors of tyrosine kinases Grant 6,153,617 - Bridges November 28, 2	2000-11-28
Irreversible inhibitors of tyrosine kinases Grant 6,127,374 - Bridges October 3, 2	2000-10-03
Substituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 6,084,095 - Bridges , et al.	2000-07-04
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 5,679,683 - Bridges , et al. Oc	1997-10-21
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family Grant 5,654,307 - Bridges , et al.	1997-08-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.